Ann: Head-to-head IIT with SAR-bisPSMA, page-118

Clarity Pharmaceuticals (CU6) | Bell Potter Healthcare Conference 2024

For the benefit of holders - I am putting this here as it provides some insights into the planned Head-Head!

Alan talks about some things we discussed in the last 2 days (my take - not a transcript);
a) The reasons and motivation to do this head-to-head,
b) The source of confidence leading to doing it,
c) [start at 7:15] The reassurance he gives around the so called 'home-brew' generic I&T GaPSMA-11 products. He says anyone can use it - it's not owned by Telix. Its also worth reading the post by @cpt_yossarian, found at https://hotcopper.com.au/threads/ann-head-to-head-iit-with-sar-bispsma.8319165/page-65?post_id=76680692.
d) The major motivation that drives him and Clarity (Cu6),
e) [start at 12:40] His view of the claimed inconvenience caused by 2nd day imaging: Clarity are not abandoning same day (it remains an option). But he believes the real inconvenience is what happens weeks later when you discover that the negative day 1 scan actually missed your cancer. (I have paraphrased this),
f) Etc!

Here it is: Clarity Pharmaceuticals (CU6) | Bell Potter Healthcare Conference 2024